The Worldwide Problem of Antifungal Resistance: From Basic to Clinic
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: 20 December 2024 | Viewed by 42
Special Issue Editors
2. Faculty of Health Sciences, Universidad Tecnológica del Perú, Lima, Peru
Interests: public health; epidemiology; infectious diseases; medical mycology; sporotrichosis; Sporothrix; subcutaneous mycoses; ocular fungal infections; implantation mycoses
Special Issues, Collections and Topics in MDPI journals
Interests: cutaneous mycoses (superficial and deep); opportunistic mycoses and antifungal treatment
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The Special Issue entitled "The Worldwide Problem of Antifungal Resistance: from Basic to Clinic" aims to present recent research on all aspects of antifungal resistance that threaten human health. Currently, invasive fungal diseases caused by resistant yeasts and moulds (e.g., fungaemia, pulmonary aspergillosis, meningitis, pneumonia) are an important and increasing public health threat. Research into the molecular mechanisms of antifungal resistance is therefore essential to understanding how fungi develop resistance and identifying new drugs. Clinical studies are also essential for monitoring the emergence and spread of this resistance in clinical and community settings. Therefore, new research is needed into the molecular mechanisms and clinical aspects of antifungal resistance, strategies for the targeted use of antifungals, and effective antifungal stewardship programmes to control resistance. In this context, the main topics of interest for this Special Issue include, but are not limited to:
- Mechanisms of antifungal resistance in yeasts, moulds and cryptic species;
- Emerging species that are resistant to antifungals;
- Azole, echinocandin, polyene and multidrug resistance;
- The epidemiology and surveillance of antifungal drug resistance;
- Factors driving the emergence of antifungal resistance;
- Preclinical and clinical research on antifungal resistant fungal pathogens;
- Antifungal stewardship programmes;
- New antifungal agents against fungal pathogens.
Dr. Max Carlos Ramírez-Soto
Prof. Dr. Alexandro Bonifaz
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antifungal agents
- antifungal resistance
- fungal pathogens
- pharmacology
- therapeutic use
